OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Looking into a Better Future: Novel Therapies for Metastatic Melanoma
Alessia Villani, Massimiliano Scalvenzi, Gabriella Fabbrocini, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 3, pp. 751-767
Open Access | Times Cited: 23

Showing 23 citing articles:

The Treatment of Advanced Melanoma: Therapeutic Update
Alessia Villani, Luca Potestio, Gabriella Fabbrocini, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6388-6388
Open Access | Times Cited: 83

Melanoma: An update on systemic therapies
Lauren Skudalski, Reid A. Waldman, Philip Kerr, et al.
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 3, pp. 515-524
Closed Access | Times Cited: 48

Identification and validation of a ferroptosis‐related gene signature for predicting survival in skin cutaneous melanoma
Ping Shuai, Siyuan Wang, Yingsong Zhao, et al.
Cancer Medicine (2022) Vol. 11, Iss. 18, pp. 3529-3541
Open Access | Times Cited: 30

Management of Advanced Invasive Melanoma: New Strategies
Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, et al.
Advances in Therapy (2023) Vol. 40, Iss. 8, pp. 3381-3394
Open Access | Times Cited: 18

Multidisciplinary approach and treatment of acral and mucosal melanoma
Ana Fortuna, Teresa Amaral
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6

Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging
Melania Parisi, Mariavittoria Verrillo, Maria Antonietta Luciano, et al.
Plants (2023) Vol. 12, Iss. 4, pp. 840-840
Open Access | Times Cited: 16

Array of Interdigitated Bipolar Electrodes for Selective Capture and Analysis of Melanoma Cells
Janis S. Borchers, Morgan J. Clark, Savanah B. Van Scoy, et al.
ChemElectroChem (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 3

Gracillin exerts anti-melanoma effects in vitro and in vivo: role of DNA damage, apoptosis and autophagy
Jun‐Kui Li, Peili Zhu, Ying Wang, et al.
Phytomedicine (2022) Vol. 108, pp. 154526-154526
Closed Access | Times Cited: 15

High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma
Markus Burkard, Heike Niessner, Christian Leischner, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 254-254
Open Access | Times Cited: 6

Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis
Domenico Mallardo, Diana Giannarelli, Maria Grazia Vitale, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e005132-e005132
Open Access | Times Cited: 9

Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF V600 Mutation-Positive Melanoma
Anna M. Czarnecka, Krzysztof Ostaszewski, Aneta Borkowska, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 110-110
Open Access | Times Cited: 12

Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo
Heike Niessner, Markus Burkard, Christian Leischner, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1229-1229
Open Access | Times Cited: 5

Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation
Alessandro Villa, Massimiliano Scalvenzi, Giuseppe Micali, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 7, pp. 525-531
Closed Access | Times Cited: 2

Prognostic modeling of patients with metastatic melanoma based on tumor immune microenvironment characteristics
Jing Liu, Bin Zhang, Ting Ye, et al.
Mathematical Biosciences & Engineering (2021) Vol. 19, Iss. 2, pp. 1448-1470
Open Access | Times Cited: 5

Enhanced intratumoral delivery of immunomodulator MPLA via hyperbranched polyglycerol-coated biodegradable nanoparticles
Jungsoo Chang, Kwangsoo Shin, Julia M. Lewis, et al.
Journal of Investigative Dermatology (2024)
Closed Access

Investigating Therapeutic Efficacy of Dacarbazine and Temozolomide, Alone and in Combination with BRAF(V600E) siRNA in A375 Human Melanoma Cell Line
Fatemeh Tabandeh, Rana Moradian Tehrani, Mohammadreza Sharifi, et al.
Research Square (Research Square) (2024)
Open Access

Unaddressed Challenges in the Treatment of Cutaneous Melanoma?
Alessia Villani, Luca Potestio, Aimilios Lallas, et al.
Medicina (2024) Vol. 60, Iss. 6, pp. 884-884
Open Access

Is Primary Breast Melanoma a True Pathological Entity? The Argument against it
Alexis Rafael Narváez-Rojas, Samantha M. Linhares, Shaina Sedighim, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37224-e37224
Open Access

A Descriptive Study of Repeated Hospitalizations and Survival of Patients with Metastatic Melanoma in the Northern Italian Region during 2004–2019
Matilde Mannucci, Vincenzo Fontana, Dalila Campanella, et al.
Current Oncology (2023) Vol. 30, Iss. 6, pp. 5266-5278
Open Access

Enrollment Trends Among Patients With Melanoma Brain Metastasis in Active Clinical Trials
Omar Elghawy, Walter Banfield, Bethany J. Horton, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top